Clinical Trial Update: Safety and Efficacy of Annual or Biannual Doses of Moxidectin or Ivermectin for Onchocerciasis [Phase 3]

View source ↗

Summary

A Phase 3 study is evaluating annual or biannual dosing of moxidectin or ivermectin for onchocerciasis, with the trial currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Onchocerciasis

Drugs mentioned

• IVERMECTIN (Ivermectin)
• Moxidectin (moxidectin)

Snippet

Sponsor: Medicines Development for Global Health | Conditions: Onchocerciasis | Phase 3 | Status: ACTIVE_NOT_RECRUITING